ORIC   $9.59  5.15% Market Closed After Close 9.59 0.0

Oric Pharmaceuticals Inc
Total Cash 286.41M
totalCashPerShare 4.06
EBITDA -124.06M
Total Debt 9.74M
quickRatio 14.658
currentRatio 15.077
Total Revenue
debtToEquity 3.22
Revenue/Share
ROA -0.25195998
ROE -0.38789
grossProfits
freeCashflow -59.14M
operatingCashflow -99.73M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 406.18M
forwardPE -5.0738916
floatShares 42.72M
sharesOutstanding 70.54M
sharesShort 12.00M
sharesShortPriorMonth 12.38M
dateShortInterest
sharesPercentSharesOut 0.17%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.99%
Short Ratio help_outline 25.72%
shortPercentOfFloat 0.17%
impliedSharesOutstanding
bookValue 4.469
Price To Book help_outline 2.30
earningsQuarterlyGrowth
netIncomeToCommon -110.78M
trailingEps -1.76%
forwardEps -2.03%
enterpriseToEbitda -3.27
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.49 3Q 2024
institutionsCount 172
lastUpdated Nov. 7, 2024, 3:14 a.m.